MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,896,800 | -72.8% | 1,890,000 | -59.9% | 0.65% | -65.5% |
| Q2 2023 | $21,641,850 | -11.2% | 4,715,000 | -4.3% | 1.89% | -5.8% |
| Q1 2023 | $24,378,750 | -53.0% | 4,925,000 | -48.2% | 2.01% | -50.1% |
| Q4 2022 | $51,897,300 | -25.6% | 9,505,000 | -11.5% | 4.02% | -12.3% |
| Q3 2022 | $69,783,000 | +5.6% | 10,735,786 | -23.2% | 4.58% | -18.0% |
| Q2 2022 | $66,084,000 | -32.3% | 13,971,334 | 0.0% | 5.59% | +27.6% |
| Q1 2022 | $97,660,000 | -31.4% | 13,971,334 | 0.0% | 4.38% | +9.1% |
| Q4 2021 | $142,368,000 | -16.5% | 13,971,334 | 0.0% | 4.01% | -5.5% |
| Q3 2021 | $170,590,000 | – | 13,971,334 | – | 4.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |